DOT1L1 Antibodies

Santa Cruz Biotechnology features a diverse variety of DOT1L1 monoclonal antibodies for research focused on understanding DOT1L1 protein function. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DOT1L1, or Disruptor of Telomeric Silencing 1, is a histone methyltransferase that catalyzes the methylation of histone H3 at lysine 79, regulating gene expression. DOT1L1 maintains proper chromatin structure and function, influencing transcriptional activation and DNA repair mechanisms. Research has shown that DOT1L1 dysfunction contributes to cancer development and developmental disorders, highlighting its potential as a therapeutic target. DOT1L1 monoclonal antibodies enable detailed investigation of molecular pathways and cellular processes involving DOT1L1. Understanding DOT1L1's role in normal cellular function and disease progression advances knowledge in epigenetic regulation and gene expression. Ongoing studies of DOT1L1 continue to reveal new insights into chromatin biology and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of DOT1L1's biological significance and therapeutic applications.